Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial
Publication
, Conference
Furie, R; Bomba, D; Dall'Era, M; Khan, A; Soneira, M; Anderl, J; Wang, J; Kirk, C; Goel, N
Published in: ARTHRITIS & RHEUMATOLOGY
October 1, 2019
Duke Scholars
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
October 1, 2019
Volume
71
Publisher
WILEY
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Furie, R., Bomba, D., Dall’Era, M., Khan, A., Soneira, M., Anderl, J., … Goel, N. (2019). Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial. In ARTHRITIS & RHEUMATOLOGY (Vol. 71). WILEY.
Furie, Richard, Darrin Bomba, Maria Dall’Era, Amber Khan, Miguel Soneira, Janet Anderl, Jinhai Wang, Christopher Kirk, and Niti Goel. “Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial.” In ARTHRITIS & RHEUMATOLOGY, Vol. 71. WILEY, 2019.
Furie R, Bomba D, Dall’Era M, Khan A, Soneira M, Anderl J, et al. Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial. In: ARTHRITIS & RHEUMATOLOGY. WILEY; 2019.
Furie, Richard, et al. “Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial.” ARTHRITIS & RHEUMATOLOGY, vol. 71, WILEY, 2019.
Furie R, Bomba D, Dall’Era M, Khan A, Soneira M, Anderl J, Wang J, Kirk C, Goel N. Treatment of SLE Patients with the Immunoproteasome Inhibitor KZR-616: Results from the First 3 Cohorts of an Open-Label Phase 1b Dose Escalation Trial. ARTHRITIS & RHEUMATOLOGY. WILEY; 2019.
Published In
ARTHRITIS & RHEUMATOLOGY
EISSN
2326-5205
ISSN
2326-5191
Publication Date
October 1, 2019
Volume
71
Publisher
WILEY
Related Subject Headings
- 3204 Immunology
- 3202 Clinical sciences